Article

jdsupra.com on 2021-12-15 20:30

Biosimilar Partnership News

Eris Lifesciences (“Eris”) announced its joint venture with Mumbai-based MJ Biopharm Pvt Ltd. (“MJ”), Eris MJ Biopharm Ltd., focused on the ...

Eris Lifesciences

Related news

Teva and Alvotech Announce Partnership in the U.S. Biosimilar Market jdsupra.com
North America , United States
BREAKING NEWS: FDA Approves Sandoz’s Erelzi, biosimilar to Enbrel (etanercept)jdsupra.com
Breaking News – FDA Approves First Interchangeable Biosimilar Insulin Product jdsupra.com
Breaking News: FDA Approves Samsung Bioepis’s Biosimilar of REMICADE®jdsupra.com
BREAKING NEWS: FDA Expected to Approve Amgen’s Humira Biosimilar Today jdsupra.com
BREAKING NEWS: FDA Denies Citizen Petitions Regarding Biosimilar Labeling jdsupra.com
Alvotech and Teva Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market jdsupra.com
North America
Denosumab Biosimilar Updates jdsupra.com
South East Asia , Taiwan , South Korea
Recent Biosimilar Commercialization Developments jdsupra.com
South Korea , China , Africa , Middle East , South East Asia
Biosimilars in India News: Recent Guidelines from India’s CDSCO and a Pending Case on “Biosimilar” Trastuzumab jdsupra.com
India
FDA Approves 25th Biosimilar jdsupra.com
California , United States , Switzerland
Recent Adalimumab Biosimilar Developments jdsupra.com
Recent Adalimumab Biosimilar Updates jdsupra.com
North America , Canada , Norway , Liechtenstein , Iceland
Biosimilar Drugs: FAQ WHIO
Texas , Austin , Seattle
Lupin Announces FDA Acceptance of aBLA for Pegfilgrastim Biosimilar jdsupra.com
India , Mumbai , Manzhouli
US Biosimilar Pathway Update jdsupra.com
Europe
Recent Biosimilar Approvals jdsupra.com
Europe , Canada , United States
FDA Accepts BLA for Dr. Reddy’s Rituximab Biosimilar for Review jdsupra.com
India , United Kingdom , United States
Alvotech and Fuji Pharma Announce Continued Biosimilar Partnership in Japan jdsupra.com
Japan
Celltrion Shares Recent Biosimilar Development News jdsupra.com
Canada